Headquarters
380 NORTHYARDS BLVD NW, ATLANTA, GA 30313-2439, US
ATLANTA, GA, US
From the company
Exvade is an oncology-focused company developing the Tumor Monorail Device, which uses bio-inspired cues to guide invasive brain tumor cells into a small, accessible reservoir where they can be safely removed and analyzed. The company is conducting a First-in-Human study of the device at the Preston Robert Tisch Brain Tumor Center at Duke University to evaluate its safety.
380 NORTHYARDS BLVD NW, ATLANTA, GA 30313-2439, US
Quantities, certifications, and timing.